A commentary on current national and international regulation of benzodiazepine-like drugs is presented. The policies and decision making associated with these regulations also are discussed, both in terms of historical mistakes and current problems. Finally, a proposal is made to improve the methods by which regulations are put into effect.
|Original language||English (US)|
|Number of pages||10|
|Journal||Journal of Clinical Pharmacology|
|State||Published - Sep 1 1998|
ASJC Scopus subject areas
- Pharmacology (medical)